CTRI/2024/07/069806Not yet recruitingUnknown
To study Memantine as an add-on drug to Escitalopram for Geriatric depression: A double-blind trial - NI
Dayanand Medical college and hospital0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Unknown
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1.The patients with a diagnosis of Major depressive disorder according to DSM-5 criteria presenting to Department of Psychiatry,DMC&H, Ludhiana
- •2.Age group 60-99 years
- •3.Score of more than or equal to 16 on the 24-item Hamilton Rating Scale for Depression (HAM-D)
- •4.Score of more than 5 on Geriatric Depression Scale
- •5.Patients who have given consent for the study
Exclusion Criteria
- •1.History of any other major psychiatric disorder
- •2.Recent or current unstable medical or neurological disorder
- •3.Diagnosis of moderate/severe cognitive impairment and patients with dementia (Dementia screening by Clinical Dementia Rating Score of 0.5)
- •4.Known allergic reaction to Escitalopram or Memantine
- •5.Patients who have not given consent for the study
Investigators
Similar Trials
Recruiting
Phase 4
Evaluation of the effect of Memantine and Escitalopram combination on Severity of Symptoms and Cognitive Function Among Patients with Obsessive-Compulsive DisorderIRCT20191106045356N11Yazd University of Medical Sciences20
Recruiting
Phase 2
Study of the efficacy of memantine in metastatic colon canceIRCT20210819052230N1Oroumia University of Medical Sciences50
Completed
Not Applicable
Memantine add on to treatment of refractory obssessive compulsive disorder: A double-blind clinical trialObsessive-compulsive disorderObsessive- Cumpulsive Disorder.IRCT138712141743N1Research Center for Behavioral Disorder and Substance Abuse, Hamadan University of Medical Sciences72
Not yet recruiting
Phase 2
Memantine in treatment of OCDObsessive-compulsive disorderIRCT20211118053093N5Shiraz University of Medical Sciences60
Active, not recruiting
Phase 1
Pharmacological treatment with memantine of oscilloscopy in patients suffering from multiple sclerosis: randomized,double blind placebo controlled study. - NDMedDRA version: 9.1Level: LLTClassification code 10028053Term: MSmultiple sclerosisEUCTR2008-000490-37-ITOSPEDALE S. RAFFAELE40